360 related articles for article (PubMed ID: 18514080)
1. Advances in evaluation of primary brain tumors.
Chen W; Silverman DH
Semin Nucl Med; 2008 Jul; 38(4):240-50. PubMed ID: 18514080
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging (PET) of brain tumors.
Basu S; Alavi A
Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of PET in brain tumors.
Chen W
J Nucl Med; 2007 Sep; 48(9):1468-81. PubMed ID: 17704239
[TBL] [Abstract][Full Text] [Related]
4. Neuronuclear assessment of patients with epilepsy.
Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
[TBL] [Abstract][Full Text] [Related]
5. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Bénard F; Romsa J; Hustinx R
Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
[TBL] [Abstract][Full Text] [Related]
6. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
[TBL] [Abstract][Full Text] [Related]
8. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Gulyás B; Halldin C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
[TBL] [Abstract][Full Text] [Related]
10. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography imaging of brain tumors.
Wong TZ; van der Westhuizen GJ; Coleman RE
Neuroimaging Clin N Am; 2002 Nov; 12(4):615-26. PubMed ID: 12687915
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
14. Single-photon emission computed tomography/computed tomography in brain tumors.
Schillaci O; Filippi L; Manni C; Santoni R
Semin Nucl Med; 2007 Jan; 37(1):34-47. PubMed ID: 17161038
[TBL] [Abstract][Full Text] [Related]
15. Applications of PET imaging of neurological tumors with radiolabeled amino acids.
Galldiks N; Langen KJ
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):70-82. PubMed ID: 25517079
[TBL] [Abstract][Full Text] [Related]
16. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion.
Borgwardt L; Højgaard L; Carstensen H; Laursen H; Nowak M; Thomsen C; Schmiegelow K
J Clin Oncol; 2005 May; 23(13):3030-7. PubMed ID: 15860860
[TBL] [Abstract][Full Text] [Related]
17. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
18. Brain tumors.
Goldman S; Pirotte BJ
Methods Mol Biol; 2011; 727():291-315. PubMed ID: 21331940
[TBL] [Abstract][Full Text] [Related]
19. [Tracers in oncology - preclinical and clinical evaluation].
Krause BJ; Schwarzenböck S; Schwaiger M
Nuklearmedizin; 2010; 49 Suppl 1():S41-5. PubMed ID: 21152689
[TBL] [Abstract][Full Text] [Related]
20. PET with radiolabeled aminoacid.
Crippa F; Alessi A; Serafini GL
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):151-62. PubMed ID: 22617237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
